Sumitomo Pharma Co., Ltd. (TYO:4506)
2,475.50
-457.50 (-15.60%)
At close: Feb 20, 2026
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of 983.49 billion as of February 20, 2026. Its market cap has increased by 334.30% in one year.
Market Cap
983.49B
Enterprise Value
1.19T
Revenue
453.40B
Ranking
n/a
PE Ratio
8.93
Stock Price
2,475.50
Market Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 983.49B, an increase of 377.58%. That is a compound annual growth rate of 4.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 983.49B | 6.79% |
| Dec 30, 2025 | 920.92B | 311.72% |
| Dec 30, 2024 | 223.67B | 20.82% |
| Dec 29, 2023 | 185.14B | -53.35% |
| Dec 30, 2022 | 396.90B | -24.60% |
| Dec 30, 2021 | 526.41B | -13.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shionogi & | 3.10T |
| Eisai | 1.44T |
| Hisamitsu Pharmaceutical Co. | 422.61B |
| Nippon Shinyaku | 338.02B |
| Tsumura & Co. | 301.98B |
| Toho Holdings | 300.48B |
| Sawai Group Holdings | 273.18B |
| Towa Pharmaceutical | 212.17B |